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1. Introduction 
Ornithine transcarbamylase (OTCase, EC 2.1.3.3) 
a mitochondrial enzyme of the urea cycle catalyses 
the formation of citrulline from ornithine and car- 
bamoyl phosphate. It has been purified from liver in 
3 mammalian species: bovine [ 11, human [2] and rat 
[3,4] but not from mouse. We decided to purify 
mouse OTCase because the mouse is the only mam- 
malian species in which two strains with an OTCase 
mutation have been described: sparse-fur (spf) and 
sparse-fur with abnormal skin and hair (spf ash) 5,6]. 
These two X-linked mutations are easily maintained 
during breeding through several generations and are 
good models for the study of OTCase mutations as 
compared to those observed in humans. 
We have been especially interested in mouse spf in 
which the OTCase activity exhibits peculiar proper- 
ties: at pH 8 which is the optimum pH of the normal 
enzyme, the spf OTCase activity is decreased by 75% 
while at pH 9 it is increased by 150% as compared to 
control OTCase measured at its optimum pH (pH 8). 
The aim of our work was to answer the question 
raised by this observation: is this increase of OTCase 
activity at pH 9 only due to a physico-chemical 
modification of the enzyme or is it secondary to an 
increased amount of this protein? This latter possi- 
bility would imply that when a mutation affects the 
quanlitative function of an enzyme of the urea cycle, 
a mechanism would be triggered resulting in an 
increased amount of the defective protein. 
We describe here the purification of OTCase from 
mouse liver and a quantitative assay of this enzyme by 
an immunological procedure [7] using a specific anti- 
serum raised in rabbit. The properties of normal and 
spf mouse livers are compared. 
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2. Materials and methods 
2.1. Animal breeding 
All the mice mentioned are either (+/Y) or (spf/+) 
males kindly supplied by I. A. Qureshi and J. Letarte 
[5]. A standard diet with 20% protein was used. 
Sparse-fur and normal males were both found to sur- 
vive after weaning on this diet but spf males were 
always hypotrophic as compared to normal males. 
2.2. Purification of normal mouse liver OTCase 
Affinity chromatography with the immobilized 
transition state analog 6-N-(phosphonacetyl)-L orni- 
thine (S-PALO) was done [4]. &-PALO was synthe- 
sized as in [8] and coupled to epoxy-activated 
Sepharose 6B on a shaker at 37°C overnight in 0.1 M 
NaOH [9]. 
Ten mouse livers (13.8 g) were homogenized in 
100 ml buffer containing 0.5% (w/v) Triton X-100, 
10 mM NaHepes (pH 7.4) and 2 mM dithiothreitol. 
After stirring for 30 min at 4°C the homogenate was 
centrifuged at 10 000 X g for 10 min and the super- 
natant was passed through a column of &-PALO 
Sepharose 6B (1 X 10 cm). The column was washed 
[4] and the OTCase was eluted with 10 mM NaHepes 
(pH 7.4) and 10 mM carbamoyl phosphate. The frac- 
tions containing the OTCase were pooled (15 ml), 
and the purity of the preparation was checked by 
electrophoresis on sodium dodecyl sulfate (SDS)- 
polyacrylamide gel [lo]. 
2.3. Determination of molecular mass (M,) 
The M, was determined by chromatography on 
Sephadex G-200 with: uricase (122 000), serum 
albumin (67 000), ovalbumin (43 000) and trypsin 
(23 000) as markers. 
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Table 1 
Purification of ornithine transcarbamylase from mouse liver 
July 1981 
Fraction Total activity Total protein Spec. act. Yield Purifi- 
(units) (mg) (units/mg) (%) cation 
Triton X-100 super- 
natant from 10 livers 2640 2016 1.3 100 
S-PALO Sepharose 6B 
fraction 2020 6.2 326 76.5 250 
The subunit Mr was determined by SDS-poly- 
acrylamide gel electrophoresis as in [ 1 I] using: phos- 
phorylase b (94 000), albumin (67 000), ovalbumin 
(43 000), carbonic anhydrase (30 000), soya bean 
trypsin inhibitor (20 100) and lactalbumin (14 100) 
as markers. 
2.4. Immunological procedure 
Antibodies against mouse OTCase were raised by 
injecting rabbits once a week for three consecutive 
weeks with 0.8 mg purified enzyme mixed with 
Freund’s adjuvant. Ten days later, the blood was col- 
lected, centrifuged and the serum analyzed by the 
Ouchterlony method [ 121 for its content in OTCase 
antibodies. Immunoelectrophoresis [ 131 was used to 
demonstrate the monospecificity of the antiserum. 
To measure the amount of OTCase protein, 
Mancini radial immunodiffusion was performed [7]. 
A straight-line relationship exists between the antigen 
concentration and the area of the terminal immuno- 
precipitate. 
2 S. Enzymatic analysis 
OTCase activity was assayed according to [ 141 
with 0.2 M triethanolamine-HCl buffer (pH 7-10) 
and the two substrates ornithine (5 mM) and car- 
bamoyl phosphate (5 mM). The activity is defined as 
the amount of citrulline formed in /*mol . min-l . mg 
protein-l. Citrulline was assayed by an automated 
calorimetric method [ 151. 
2.6. Preparation of homogenates and mitochondria 
Liver extracts from normal and spf mice were 
homogenized in 14 vol. cold 0.1% cetyltrimethyl- 
ammonium bromide and used directly for the deter- 
mination of protein concentration and Mancini radial 
immunodiffusion. Liver mitochondria were isolated 
from normal and spf mice as in [ 161 in 0.27 M sac- 
charose and 2 mM Tris-HCl (pH 7.4). 
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3. Results and discussion 
3.1, Purification and molecular weight determination 
of mouse ornithine transcarbamylase 
The purification procedure of normal mouse 
OTCase is given in table 1. In 6 different experiments 
the yield was 75-85%, and spec. act. 280-330 pmol . 
min-’ . mg OTCase-l. The purity of the OTCase prep- 
arations was checked by acrylamide gel electrophore- 
sis (fig.lA). The Mr was 98 000 as determined by 
Sephadex G-200 filtration (not shown) and the sub- 
unit Mr was 36 000 (fig.1 B). These results agree with 
a trimeric structure reported for rat [3,4], bovine [I] 
and human [2] OTCase. 
Using the purified mouse OTCase we obtained a 
rabbit monospecific antiserum (fig.2). After electro- 
phoresis of mouse liver homogenate and of purified 
OTCase, only one precipitation arc was observed by 
development with a rabbit antiserum raised against 
purified mouse OTCase; there is no precipitation arc 
0.2 0.4 0.6 0.8 1.0 
Re = distance protein has migrated from origin 
dostance from origin to reference point 
Fip.1. SDS-polyacrylamide gel pattern of purified OTCase of 
normal mouse: (A) 13 pg protein were applied onto the gel at 
the level of line 1. The dye front is indicated by line 2; (B) 
purified OTCase (8 fig) and markers were subjected to elec- 
trophoresis [IO]. 
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-ig.2. Immunoelectrophoresis [ 1 l] of mouse liver homoge- 
nate (1 mg protein in wells I ,3,5) and of purified mouse 
OTCase (2 pg in wells 2,4). After electrophoresis (IO V/cm, 
2 h) the precipitation pattern was developed with a rabbit 
antiserum raised against purified mouse OTCase (a,b) and 
with control rabbit antiserum (c,d). 
after development with control rabbit serum. 
The purification of spf mouse OTCase by the same 
procedure gives lower yields (-10%); very minor 
impurities were detectable when the preparation was 
checked by acrylamide gel electrophoresis (not shown). 
3.2. Determination of the amount of OTCprotein 
in liver homogenates and mitochondria from 
normal and spf mice 
Radial immunodiffusion clearly demonstrates 
(fig.3) that there is more OTCase cross-reactive mate- 
rial (CRM) in spf than in wild-type hepatic homoge- 
nate. In 5 different experiments, we always found spf 
1 2 
Fig.3. Radial immunodiffusion of liver homogenate and mito- 
chondria from spf and normal mouse; identical amounts of 
protein (1 mg liver extracts (1) and 0.2 mg mitochondria (2)) 
from normal (a) and spf (b) mouse were placed on an agarose 
gel containing anti-mouse OTC&c (70 Mg/ml). 
CRM/control CRM ratios of 1 .l-1.5 (?Fi = 1.2 f 0.06 
SEM). The problem was to define which form of the 
molecule results in the increase of CRM observed. 
OTCase is synthesized as a larger cytosolic precursor 
which may be imported into mitochondria concomi- 
tantly with post-translational processing to yield 
mature OTCase [ 17,181. When radial immunodiffu- 
sion was performed with isolated mitochondria, the 
same ratio for spf CRM/control CRM was found 
[ 1,2]. This indicates that mature intra-mitochondrial 
OTCase is increased in spf mice and rules out the pos- 
sibility of a mitochondrial membrane defect in the 
transport of spf pre-OTCase from the cytosol. 
3.3. Determination of OTCase activity as a function 
ofpH 
Kinetic abnormalities of spf OTCase activity as a 
function of pH in liver homogenates have been 
reported [5,6]. Optimum activity is found at pH 9. 
At this pH, the spf OTCase activity is higher than the 
activity of the normal enzyme at pH 8, its optimum 
pH. We found that the ratio spf OTCase at pH 9/ton- 
trol OTCase at pH 8 was 1.45 f 0.05 SEM. The 
kinetic abnormalities of partially purified spf OTCase 
are the same as in total homogenate (fig.4). Because 
spf OTCase was not completely purified, the true 
value of the enzyme concentration was determined 
by Mancini immunodiffusion. The specific activity at 
pH 9 was 400 f 30 pmol . min-' . mg spf OTCase-‘, 
while the optimum (pH 8) specific activity of purified 
normal enzyme was 300 + 30 pm01 _ min-’ . mg 
OTCase-‘. 
I I I 1 I I I 
7 7.5 8 8.5 9 9.5 10 pH 
Fig.4. Variations of the activities of normal and spf mouse 
OTC&e as a function of pH. The activiv is expressed in pmol 
citrulline formed . h-’ mg OTCase-’ as measured by radial 
immunodiffusion: (0) normal OTCase; (0) spf OTCase. 
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